Topic: Colleen Boyle

The discussion shifts to high-level CDC officials, specifically Dr. Julie Gerberding and Colleen Boyle, who are accused of facilitating fraudulent studies. Grundvig notes that Gerberding transitioned from the CDC to a leadership role at Merck, while Boyle remains at the CDC despite her controversial history with Agent Orange studies. There is an expressed hope that the Donald Trump administration will take action against these individuals.

James Grundvig explains specific methods used by Colleen Boyle to fudge vaccine data, such as widening the diagnostic scope to suppress autism spikes. By altering eligibility criteria and ignoring certain data sets, the CDC allegedly ensured that studies showed no association between vaccines and developmental disorders. These deviations from original scientific protocols are presented as major red flags regarding the validity of the research.

Congressman Bill Posey’s questioning of Colleen Boyle is highlighted, revealing that the CDC has never conducted a true study comparing vaccinated children to completely unvaccinated children. Instead, the agency compares children on different schedules, which Grundvig argues masks the true risk of autism. The lack of a placebo-controlled study is cited as a fundamental failure in proving vaccine safety.

The segment explores Colleen Boyle’s history with the 1980s Agent Orange studies, where she allegedly helped clear Monsanto of wrongdoing by prematurely ending research. Grundvig argues that Boyle used the same template of "finding no association" for Agent Orange to later dismiss vaccine-autism links. This history of corruption is presented as the reason for her continued promotion within the CDC.